Pancreatic Neuroendocrine Neoplasm clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
open to eligible people ages 18 years and up
This is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating locations with a new or existing diagnosis of Pancreatic Neuroendocrine Neoplasms (PanNEN). This protocol is an extension of existing Genetic Testing Station efforts at University of California, San Francisco (UCSF)
at UCLA UCSD UCSF
Our lead scientists for Pancreatic Neuroendocrine Neoplasm research studies include Emily Bergsland, MD.